相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mitochondrial dysfunction in neurons in Friedreich's ataxia
Anna Stepanova et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2020)
Mitoprotective Clinical Strategies in Type 2 Diabetes and Fanconi Anemia Patients: Suggestions for Clinical Management of Mitochondrial Dysfunction
Giovanni Pagano et al.
ANTIOXIDANTS (2020)
Antioxidant Therapies and Oxidative Stress in Friedreich's Ataxia: The Right Path or Just a Diversion?
Laura R. Rodriguez et al.
ANTIOXIDANTS (2020)
Targeting ferroptosis: A novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsy
Amanda H. Kahn-Kirby et al.
PLOS ONE (2019)
New developments in pharmacotherapy for Friedreich ataxia
Alexandra Clay et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Friedreich ataxia- pathogenesis and implications for therapies
Martin B. Delatycki et al.
NEUROBIOLOGY OF DISEASE (2019)
Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice
Weixing Zhao et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Quantitative Proteomic and Network Analysis of Differentially Expressed Proteins in PBMC of Friedreich's Ataxia (FRDA) Patients
Deepti Pathak et al.
FRONTIERS IN NEUROSCIENCE (2019)
Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia
David R. Lynch et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Randomized, Clinical Trial of RT001: Early Signals of Efficacy in Friedreich's Ataxia
Theresa Zesiewicz et al.
MOVEMENT DISORDERS (2018)
Double-blind, randomized and controlled trial of EPI-743 in Friedreich's ataxia
Theresa Zesiewicz et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2018)
Pharmacological therapeutics in Friedreich ataxia: the present state
Cassandra Strawser et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Pharmacological therapeutics in Friedreich ataxia: the present state
Cassandra Strawser et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Reversible Axonal Dystrophy by Calcium Modulation in Frataxin-Deficient Sensory Neurons of YG8R Mice
Belen Molla et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Friedreich's ataxia: clinical features, pathogenesis and management
A. Cook et al.
BRITISH MEDICAL BULLETIN (2017)
An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels
Eppie M. Yiu et al.
JOURNAL OF NEUROLOGY (2015)
Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia - open-label trial
J. Arpa et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Deferiprone in Friedreich Ataxia: A 6-Month Randomized Controlled Trial
Massimo Pandolfo et al.
ANNALS OF NEUROLOGY (2014)
Mitochondrial Enhancement for Neurodegenerative Movement Disorders: A Systematic Review of Trials Involving Creatine, Coenzyme Q10, Idebenone and Mitoquinone
Jia Liu et al.
CNS DRUGS (2014)
Mitochondria in ageing: there is metabolism beyond the ROS
Michael Breitenbach et al.
FEMS YEAST RESEARCH (2014)
Current Experience in Testing Mitochondrial Nutrients in Disorders Featuring Oxidative Stress and Mitochondrial Dysfunction: Rational Design of Chemoprevention Trials
Giovanni Pagano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Aconitase post-translational modification as a key in linkage between Krebs cycle, iron homeostasis, redox signaling, and metabolism of reactive oxygen species
Oleh V. Lushchak et al.
REDOX REPORT (2014)
Triple Therapy with Darbepoetin Alfa, Idebenone, and Riboflavin in Friedreich's Ataxia: an Open-Label Trial
Javier Arpa et al.
CEREBELLUM (2013)
Co-enzyme Q10 and idebenone use in Friedreich's ataxia
Michael H. Parkinson et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Mitochondrial pathophysiology in Friedreich's ataxia
Pilar Gonzalez-Cabo et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Clinical features of Friedreich's ataxia: classical and atypical phenotypes
Michael H. Parkinson et al.
JOURNAL OF NEUROCHEMISTRY (2013)
A0001 in Friedreich ataxia: Biochemical characterization and effects in a clinical trial
David R. Lynch et al.
MOVEMENT DISORDERS (2012)
Targeting Mitochondrial Dysfunction and Neurodegeneration by Means of Coenzyme Q10 and its Analogues
D. Orsucci et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Molecular control of the cytosolic aconitase/IRP1 switch by extramitochondrial frataxin
Ivano Condo et al.
HUMAN MOLECULAR GENETICS (2010)
Flavin Adenine Dinucleotide Rescues the Phenotype of Frataxin Deficiency
Pilar Gonzalez-Cabo et al.
PLOS ONE (2010)
Alpha-lipoic acid and frataxin: A new indication for an old antioxidant?
James W. Russell
EXPERIMENTAL NEUROLOGY (2009)
Coenzyme Q10 and Neurological Diseases
Michelangelo Mancuso et al.
PHARMACEUTICALS (2009)
The mitochondrial cocktail: Rationale for combined nutraceutical therapy in mitochondrial cytopathies
M. A. Tarnopolsky
ADVANCED DRUG DELIVERY REVIEWS (2008)
Human CoQ(10) deficiencies
C. M. Quinzii et al.
BIOFACTORS (2008)
Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy
J. M. Cooper et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy
Giorgia Melli et al.
EXPERIMENTAL NEUROLOGY (2008)
Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders
M. Christine Rodriguez et al.
MUSCLE & NERVE (2007)
Frataxin interacts functionally with mitochondrial electron transport chain proteins
P González-Cabo et al.
HUMAN MOLECULAR GENETICS (2005)
L-carnitine and creatine in Friedreich's ataxia.: A randomized, placebo-controlled crossover trial
L Schöls et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Antioxidant treatment of patients with Friedreich ataxia - Four-year follow-up
PE Hart et al.
ARCHIVES OF NEUROLOGY (2005)
A cellular model for Friedreich Ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy
ML Jauslin et al.
HUMAN MOLECULAR GENETICS (2002)
Glutathione in blood of patients with Friedreich's ataxia
F Piemonte et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2001)
Familial cerebellar ataxia with muscle coenzyme Q10 deficiency
O Musumeci et al.
NEUROLOGY (2001)
Increased levels of plasma malondialdehyde in Friedreich ataxia
M Emond et al.
NEUROLOGY (2000)
Frataxin activates mitochondrial energy conversion and oxidative phosphorylation
M Ristow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia
JL Bradley et al.
HUMAN MOLECULAR GENETICS (2000)
分享论文
